Back to results
US 2016/0103132 A1Published application
Method of diagnosing cancer
AssigneeApogenix AG
InventorsHarald FRICKE, Christian GIEFFERS, Jaromir SYKORA
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for diagnosing a cancer disease, comprising (a) determining the expression of CD95L in a cancer sample, and (b) classifying the cancer disease according the level of CD95L expression.
Claims20
A method for diagnosing a cancer disease, comprising:
- (a) determining the expression of CD95L in a cancer sample, and
- (b) classifying the cancer disease according the level of CD95L expression.
A method of prognosing the overall survival time or/and the relaps-free survival time in a cancer patient, said method comprising:
- (a) determining CD95L expression in a cancer sample, and
- (b) prognosing the survival time or/and the relaps-free survival time of the patient by the level of CD95L expression, wherein the CD95L expression is negatively correlated with the survival time of the patient.
A method of treatment of cancer, said method comprising:
- (a) determining the expression of CD95L in a cancer sample obtained from a patient, and
- (b) administrating a CD95L inhibitor, if in step (a), expression of CD95L has been detected in the cancer sample.
Dependencies are inferred from the claim text.